 | • レポートコード：GIR-107A11790 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：産業機械＆装置 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、がん治療における感染管理のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。がん治療における感染管理の種類別市場規模（放射線療法、免疫療法、従来型手術、幹細胞移植療法、化学療法、標的療法、光力学的療法、その他）、用途別市場規模（病院、製薬会社、医療機器会社、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・がん治療における感染管理の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Kimberly Clark Corporation、3M Healthcare Company、Honeywell International, Inc.、Getinge Group AB、Sterigenics International、Sakura Global Holding Company、Arizant Healthcare Inc.、Nordion、Cisa S.P.A.、Steris Corporation、Nordion, Inc.、Ahlstrom Filtration LLC、Membrana GmbH、Synergy Health, Plc、Advanced Sterilization Products Services, Inc ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：放射線療法、免疫療法、従来型手術、幹細胞移植療法、化学療法、標的療法、光力学的療法、その他 ・用途別分析2016年-2026年：病院、製薬会社、医療機器会社、その他 ・がん治療における感染管理の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・がん治療における感染管理のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・がん治療における感染管理のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・がん治療における感染管理の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・がん治療における感染管理の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Infection Control in Cancer Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Infection Control in Cancer Therapy size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Infection Control in Cancer Therapy market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Infection Control in Cancer Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Radiation Therapy
Immunotherapy
Traditional Surgery
Stem Cell Transplant Therapy
Chemotherapy
Targeted Therapy
Photodynamic Therapy
Other
Market segment by Application, can be divided into
Hospital
Pharmaceutical Companies
Medical device companies
Other
Market segment by players, this report covers
Kimberly Clark Corporation
3M Healthcare Company
Honeywell International, Inc.
Getinge Group AB
Sterigenics International
Sakura Global Holding Company
Arizant Healthcare Inc.
Nordion
Cisa S.P.A.
Steris Corporation
Nordion, Inc.
Ahlstrom Filtration LLC
Membrana GmbH
Synergy Health, Plc
Advanced Sterilization Products Services, Inc
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Infection Control in Cancer Therapy
1.2 Classification of Infection Control in Cancer Therapy by Type
1.2.1 Overview: Global Infection Control in Cancer Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Infection Control in Cancer Therapy Revenue Market Share by Type in 2020
1.2.3 Radiation Therapy
1.2.4 Immunotherapy
1.2.5 Traditional Surgery
1.2.6 Stem Cell Transplant Therapy
1.2.7 Chemotherapy
1.2.8 Targeted Therapy
1.2.9 Photodynamic Therapy
1.2.10 Other
1.3 Global Infection Control in Cancer Therapy Market by Application
1.3.1 Overview: Global Infection Control in Cancer Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Pharmaceutical Companies
1.3.4 Medical device companies
1.3.5 Other
1.4 Global Infection Control in Cancer Therapy Market Size & Forecast
1.5 Global Infection Control in Cancer Therapy Market Size and Forecast by Region
1.5.1 Global Infection Control in Cancer Therapy Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Infection Control in Cancer Therapy Market Size by Region, (2016-2021)
1.5.3 North America Infection Control in Cancer Therapy Market Size and Prospect (2016-2026)
1.5.4 Europe Infection Control in Cancer Therapy Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Infection Control in Cancer Therapy Market Size and Prospect (2016-2026)
1.5.6 South America Infection Control in Cancer Therapy Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Infection Control in Cancer Therapy Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Infection Control in Cancer Therapy Market Drivers
1.6.2 Infection Control in Cancer Therapy Market Restraints
1.6.3 Infection Control in Cancer Therapy Trends Analysis
2 Company Profiles
2.1 Kimberly Clark Corporation
2.1.1 Kimberly Clark Corporation Details
2.1.2 Kimberly Clark Corporation Major Business
2.1.3 Kimberly Clark Corporation Infection Control in Cancer Therapy Product and Solutions
2.1.4 Kimberly Clark Corporation Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Kimberly Clark Corporation Recent Developments and Future Plans
2.2 3M Healthcare Company
2.2.1 3M Healthcare Company Details
2.2.2 3M Healthcare Company Major Business
2.2.3 3M Healthcare Company Infection Control in Cancer Therapy Product and Solutions
2.2.4 3M Healthcare Company Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 3M Healthcare Company Recent Developments and Future Plans
2.3 Honeywell International, Inc.
2.3.1 Honeywell International, Inc. Details
2.3.2 Honeywell International, Inc. Major Business
2.3.3 Honeywell International, Inc. Infection Control in Cancer Therapy Product and Solutions
2.3.4 Honeywell International, Inc. Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Honeywell International, Inc. Recent Developments and Future Plans
2.4 Getinge Group AB
2.4.1 Getinge Group AB Details
2.4.2 Getinge Group AB Major Business
2.4.3 Getinge Group AB Infection Control in Cancer Therapy Product and Solutions
2.4.4 Getinge Group AB Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Getinge Group AB Recent Developments and Future Plans
2.5 Sterigenics International
2.5.1 Sterigenics International Details
2.5.2 Sterigenics International Major Business
2.5.3 Sterigenics International Infection Control in Cancer Therapy Product and Solutions
2.5.4 Sterigenics International Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Sterigenics International Recent Developments and Future Plans
2.6 Sakura Global Holding Company
2.6.1 Sakura Global Holding Company Details
2.6.2 Sakura Global Holding Company Major Business
2.6.3 Sakura Global Holding Company Infection Control in Cancer Therapy Product and Solutions
2.6.4 Sakura Global Holding Company Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Sakura Global Holding Company Recent Developments and Future Plans
2.7 Arizant Healthcare Inc.
2.7.1 Arizant Healthcare Inc. Details
2.7.2 Arizant Healthcare Inc. Major Business
2.7.3 Arizant Healthcare Inc. Infection Control in Cancer Therapy Product and Solutions
2.7.4 Arizant Healthcare Inc. Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Arizant Healthcare Inc. Recent Developments and Future Plans
2.8 Nordion
2.8.1 Nordion Details
2.8.2 Nordion Major Business
2.8.3 Nordion Infection Control in Cancer Therapy Product and Solutions
2.8.4 Nordion Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Nordion Recent Developments and Future Plans
2.9 Cisa S.P.A.
2.9.1 Cisa S.P.A. Details
2.9.2 Cisa S.P.A. Major Business
2.9.3 Cisa S.P.A. Infection Control in Cancer Therapy Product and Solutions
2.9.4 Cisa S.P.A. Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Cisa S.P.A. Recent Developments and Future Plans
2.10 Steris Corporation
2.10.1 Steris Corporation Details
2.10.2 Steris Corporation Major Business
2.10.3 Steris Corporation Infection Control in Cancer Therapy Product and Solutions
2.10.4 Steris Corporation Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Steris Corporation Recent Developments and Future Plans
2.11 Nordion, Inc.
2.11.1 Nordion, Inc. Details
2.11.2 Nordion, Inc. Major Business
2.11.3 Nordion, Inc. Infection Control in Cancer Therapy Product and Solutions
2.11.4 Nordion, Inc. Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Nordion, Inc. Recent Developments and Future Plans
2.12 Ahlstrom Filtration LLC
2.12.1 Ahlstrom Filtration LLC Details
2.12.2 Ahlstrom Filtration LLC Major Business
2.12.3 Ahlstrom Filtration LLC Infection Control in Cancer Therapy Product and Solutions
2.12.4 Ahlstrom Filtration LLC Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Ahlstrom Filtration LLC Recent Developments and Future Plans
2.13 Membrana GmbH
2.13.1 Membrana GmbH Details
2.13.2 Membrana GmbH Major Business
2.13.3 Membrana GmbH Infection Control in Cancer Therapy Product and Solutions
2.13.4 Membrana GmbH Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Membrana GmbH Recent Developments and Future Plans
2.14 Synergy Health, Plc
2.14.1 Synergy Health, Plc Details
2.14.2 Synergy Health, Plc Major Business
2.14.3 Synergy Health, Plc Infection Control in Cancer Therapy Product and Solutions
2.14.4 Synergy Health, Plc Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Synergy Health, Plc Recent Developments and Future Plans
2.15 Advanced Sterilization Products Services, Inc
2.15.1 Advanced Sterilization Products Services, Inc Details
2.15.2 Advanced Sterilization Products Services, Inc Major Business
2.15.3 Advanced Sterilization Products Services, Inc Infection Control in Cancer Therapy Product and Solutions
2.15.4 Advanced Sterilization Products Services, Inc Infection Control in Cancer Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Advanced Sterilization Products Services, Inc Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Infection Control in Cancer Therapy Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Infection Control in Cancer Therapy Players Market Share
3.2.2 Top 10 Infection Control in Cancer Therapy Players Market Share
3.2.3 Market Competition Trend
3.3 Infection Control in Cancer Therapy Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Infection Control in Cancer Therapy Revenue and Market Share by Type (2016-2021)
4.2 Global Infection Control in Cancer Therapy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Infection Control in Cancer Therapy Revenue Market Share by Application (2016-2021)
5.2 Infection Control in Cancer Therapy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Infection Control in Cancer Therapy Revenue by Type (2016-2026)
6.2 North America Infection Control in Cancer Therapy Revenue by Application (2016-2026)
6.3 North America Infection Control in Cancer Therapy Market Size by Country
6.3.1 North America Infection Control in Cancer Therapy Revenue by Country (2016-2026)
6.3.2 United States Infection Control in Cancer Therapy Market Size and Forecast (2016-2026)
6.3.3 Canada Infection Control in Cancer Therapy Market Size and Forecast (2016-2026)
6.3.4 Mexico Infection Control in Cancer Therapy Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Infection Control in Cancer Therapy Revenue by Type (2016-2026)
7.2 Europe Infection Control in Cancer Therapy Revenue by Application (2016-2026)
7.3 Europe Infection Control in Cancer Therapy Market Size by Country
7.3.1 Europe Infection Control in Cancer Therapy Revenue by Country (2016-2026)
7.3.2 Germany Infection Control in Cancer Therapy Market Size and Forecast (2016-2026)
7.3.3 France Infection Control in Cancer Therapy Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Infection Control in Cancer Therapy Market Size and Forecast (2016-2026)
7.3.5 Russia Infection Control in Cancer Therapy Market Size and Forecast (2016-2026)
7.3.6 Italy Infection Control in Cancer Therapy Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Infection Control in Cancer Therapy Revenue by Type (2016-2026)
8.2 Asia-Pacific Infection Control in Cancer Therapy Revenue by Application (2016-2026)
8.3 Asia-Pacific Infection Control in Cancer Therapy Market Size by Region
8.3.1 Asia-Pacific Infection Control in Cancer Therapy Revenue by Region (2016-2026)
8.3.2 China Infection Control in Cancer Therapy Market Size and Forecast (2016-2026)
8.3.3 Japan Infection Control in Cancer Therapy Market Size and Forecast (2016-2026)
8.3.4 South Korea Infection Control in Cancer Therapy Market Size and Forecast (2016-2026)
8.3.5 India Infection Control in Cancer Therapy Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Infection Control in Cancer Therapy Market Size and Forecast (2016-2026)
8.3.7 Australia Infection Control in Cancer Therapy Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Infection Control in Cancer Therapy Revenue by Type (2016-2026)
9.2 South America Infection Control in Cancer Therapy Revenue by Application (2016-2026)
9.3 South America Infection Control in Cancer Therapy Market Size by Country
9.3.1 South America Infection Control in Cancer Therapy Revenue by Country (2016-2026)
9.3.2 Brazil Infection Control in Cancer Therapy Market Size and Forecast (2016-2026)
9.3.3 Argentina Infection Control in Cancer Therapy Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Infection Control in Cancer Therapy Revenue by Type (2016-2026)
10.2 Middle East & Africa Infection Control in Cancer Therapy Revenue by Application (2016-2026)
10.3 Middle East & Africa Infection Control in Cancer Therapy Market Size by Country
10.3.1 Middle East & Africa Infection Control in Cancer Therapy Revenue by Country (2016-2026)
10.3.2 Turkey Infection Control in Cancer Therapy Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Infection Control in Cancer Therapy Market Size and Forecast (2016-2026)
10.3.4 UAE Infection Control in Cancer Therapy Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Infection Control in Cancer Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Infection Control in Cancer Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Infection Control in Cancer Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Infection Control in Cancer Therapy Revenue (USD Million) by Region (2016-2021)
Table 5. Global Infection Control in Cancer Therapy Revenue Market Share by Region (2021-2026)
Table 6. Kimberly Clark Corporation Corporate Information, Head Office, and Major Competitors
Table 7. Kimberly Clark Corporation Major Business
Table 8. Kimberly Clark Corporation Infection Control in Cancer Therapy Product and Solutions
Table 9. Kimberly Clark Corporation Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. 3M Healthcare Company Corporate Information, Head Office, and Major Competitors
Table 11. 3M Healthcare Company Major Business
Table 12. 3M Healthcare Company Infection Control in Cancer Therapy Product and Solutions
Table 13. 3M Healthcare Company Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Honeywell International, Inc. Corporate Information, Head Office, and Major Competitors
Table 15. Honeywell International, Inc. Major Business
Table 16. Honeywell International, Inc. Infection Control in Cancer Therapy Product and Solutions
Table 17. Honeywell International, Inc. Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Getinge Group AB Corporate Information, Head Office, and Major Competitors
Table 19. Getinge Group AB Major Business
Table 20. Getinge Group AB Infection Control in Cancer Therapy Product and Solutions
Table 21. Getinge Group AB Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Sterigenics International Corporate Information, Head Office, and Major Competitors
Table 23. Sterigenics International Major Business
Table 24. Sterigenics International Infection Control in Cancer Therapy Product and Solutions
Table 25. Sterigenics International Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Sakura Global Holding Company Corporate Information, Head Office, and Major Competitors
Table 27. Sakura Global Holding Company Major Business
Table 28. Sakura Global Holding Company Infection Control in Cancer Therapy Product and Solutions
Table 29. Sakura Global Holding Company Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Arizant Healthcare Inc. Corporate Information, Head Office, and Major Competitors
Table 31. Arizant Healthcare Inc. Major Business
Table 32. Arizant Healthcare Inc. Infection Control in Cancer Therapy Product and Solutions
Table 33. Arizant Healthcare Inc. Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Nordion Corporate Information, Head Office, and Major Competitors
Table 35. Nordion Major Business
Table 36. Nordion Infection Control in Cancer Therapy Product and Solutions
Table 37. Nordion Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Cisa S.P.A. Corporate Information, Head Office, and Major Competitors
Table 39. Cisa S.P.A. Major Business
Table 40. Cisa S.P.A. Infection Control in Cancer Therapy Product and Solutions
Table 41. Cisa S.P.A. Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Steris Corporation Corporate Information, Head Office, and Major Competitors
Table 43. Steris Corporation Major Business
Table 44. Steris Corporation Infection Control in Cancer Therapy Product and Solutions
Table 45. Steris Corporation Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Nordion, Inc. Corporate Information, Head Office, and Major Competitors
Table 47. Nordion, Inc. Major Business
Table 48. Nordion, Inc. Infection Control in Cancer Therapy Product and Solutions
Table 49. Nordion, Inc. Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Ahlstrom Filtration LLC Corporate Information, Head Office, and Major Competitors
Table 51. Ahlstrom Filtration LLC Major Business
Table 52. Ahlstrom Filtration LLC Infection Control in Cancer Therapy Product and Solutions
Table 53. Ahlstrom Filtration LLC Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Membrana GmbH Corporate Information, Head Office, and Major Competitors
Table 55. Membrana GmbH Major Business
Table 56. Membrana GmbH Infection Control in Cancer Therapy Product and Solutions
Table 57. Membrana GmbH Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Synergy Health, Plc Corporate Information, Head Office, and Major Competitors
Table 59. Synergy Health, Plc Major Business
Table 60. Synergy Health, Plc Infection Control in Cancer Therapy Product and Solutions
Table 61. Synergy Health, Plc Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Advanced Sterilization Products Services, Inc Corporate Information, Head Office, and Major Competitors
Table 63. Advanced Sterilization Products Services, Inc Major Business
Table 64. Advanced Sterilization Products Services, Inc Infection Control in Cancer Therapy Product and Solutions
Table 65. Advanced Sterilization Products Services, Inc Infection Control in Cancer Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Global Infection Control in Cancer Therapy Revenue (USD Million) by Players (2019-2021)
Table 67. Global Infection Control in Cancer Therapy Revenue Share by Players (2019-2021)
Table 68. Breakdown of Infection Control in Cancer Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Infection Control in Cancer Therapy Players Head Office, Products and Services Provided
Table 70. Infection Control in Cancer Therapy Mergers & Acquisitions in the Past Five Years
Table 71. Infection Control in Cancer Therapy New Entrants and Expansion Plans
Table 72. Global Infection Control in Cancer Therapy Revenue (USD Million) by Type (2016-2021)
Table 73. Global Infection Control in Cancer Therapy Revenue Share by Type (2016-2021)
Table 74. Global Infection Control in Cancer Therapy Revenue Forecast by Type (2021-2026)
Table 75. Global Infection Control in Cancer Therapy Revenue by Application (2016-2021)
Table 76. Global Infection Control in Cancer Therapy Revenue Forecast by Application (2021-2026)
Table 77. North America Infection Control in Cancer Therapy Revenue by Type (2016-2021) & (USD Million)
Table 78. North America Infection Control in Cancer Therapy Revenue by Type (2021-2026) & (USD Million)
Table 79. North America Infection Control in Cancer Therapy Revenue by Application (2016-2021) & (USD Million)
Table 80. North America Infection Control in Cancer Therapy Revenue by Application (2021-2026) & (USD Million)
Table 81. North America Infection Control in Cancer Therapy Revenue by Country (2016-2021) & (USD Million)
Table 82. North America Infection Control in Cancer Therapy Revenue by Country (2021-2026) & (USD Million)
Table 83. Europe Infection Control in Cancer Therapy Revenue by Type (2016-2021) & (USD Million)
Table 84. Europe Infection Control in Cancer Therapy Revenue by Type (2021-2026) & (USD Million)
Table 85. Europe Infection Control in Cancer Therapy Revenue by Application (2016-2021) & (USD Million)
Table 86. Europe Infection Control in Cancer Therapy Revenue by Application (2021-2026) & (USD Million)
Table 87. Europe Infection Control in Cancer Therapy Revenue by Country (2016-2021) & (USD Million)
Table 88. Europe Infection Control in Cancer Therapy Revenue by Country (2021-2026) & (USD Million)
Table 89. Asia-Pacific Infection Control in Cancer Therapy Revenue by Type (2016-2021) & (USD Million)
Table 90. Asia-Pacific Infection Control in Cancer Therapy Revenue by Type (2021-2026) & (USD Million)
Table 91. Asia-Pacific Infection Control in Cancer Therapy Revenue by Application (2016-2021) & (USD Million)
Table 92. Asia-Pacific Infection Control in Cancer Therapy Revenue by Application (2021-2026) & (USD Million)
Table 93. Asia-Pacific Infection Control in Cancer Therapy Revenue by Region (2016-2021) & (USD Million)
Table 94. Asia-Pacific Infection Control in Cancer Therapy Revenue by Region (2021-2026) & (USD Million)
Table 95. South America Infection Control in Cancer Therapy Revenue by Type (2016-2021) & (USD Million)
Table 96. South America Infection Control in Cancer Therapy Revenue by Type (2021-2026) & (USD Million)
Table 97. South America Infection Control in Cancer Therapy Revenue by Application (2016-2021) & (USD Million)
Table 98. South America Infection Control in Cancer Therapy Revenue by Application (2021-2026) & (USD Million)
Table 99. South America Infection Control in Cancer Therapy Revenue by Country (2016-2021) & (USD Million)
Table 100. South America Infection Control in Cancer Therapy Revenue by Country (2021-2026) & (USD Million)
Table 101. Middle East & Africa Infection Control in Cancer Therapy Revenue by Type (2016-2021) & (USD Million)
Table 102. Middle East & Africa Infection Control in Cancer Therapy Revenue by Type (2021-2026) & (USD Million)
Table 103. Middle East & Africa Infection Control in Cancer Therapy Revenue by Application (2016-2021) & (USD Million)
Table 104. Middle East & Africa Infection Control in Cancer Therapy Revenue by Application (2021-2026) & (USD Million)
Table 105. Middle East & Africa Infection Control in Cancer Therapy Revenue by Country (2016-2021) & (USD Million)
Table 106. Middle East & Africa Infection Control in Cancer Therapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Infection Control in Cancer Therapy Picture
Figure 2. Global Infection Control in Cancer Therapy Revenue Market Share by Type in 2020
Figure 3. Radiation Therapy
Figure 4. Immunotherapy
Figure 5. Traditional Surgery
Figure 6. Stem Cell Transplant Therapy
Figure 7. Chemotherapy
Figure 8. Targeted Therapy
Figure 9. Photodynamic Therapy
Figure 10. Other
Figure 11. Infection Control in Cancer Therapy Revenue Market Share by Application in 2020
Figure 12. Hospital Picture
Figure 13. Pharmaceutical Companies Picture
Figure 14. Medical device companies Picture
Figure 15. Other Picture
Figure 16. Global Infection Control in Cancer Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 17. Global Infection Control in Cancer Therapy Revenue and Forecast (2016-2026) & (USD Million)
Figure 18. Global Infection Control in Cancer Therapy Revenue Market Share by Region (2016-2026)
Figure 19. Global Infection Control in Cancer Therapy Revenue Market Share by Region in 2020
Figure 20. North America Infection Control in Cancer Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Europe Infection Control in Cancer Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Asia-Pacific Infection Control in Cancer Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. South America Infection Control in Cancer Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 24. Middle East and Africa Infection Control in Cancer Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 25. Infection Control in Cancer Therapy Market Drivers
Figure 26. Infection Control in Cancer Therapy Market Restraints
Figure 27. Infection Control in Cancer Therapy Market Trends
Figure 28. Kimberly Clark Corporation Recent Developments and Future Plans
Figure 29. 3M Healthcare Company Recent Developments and Future Plans
Figure 30. Honeywell International, Inc. Recent Developments and Future Plans
Figure 31. Getinge Group AB Recent Developments and Future Plans
Figure 32. Sterigenics International Recent Developments and Future Plans
Figure 33. Sakura Global Holding Company Recent Developments and Future Plans
Figure 34. Arizant Healthcare Inc. Recent Developments and Future Plans
Figure 35. Nordion Recent Developments and Future Plans
Figure 36. Cisa S.P.A. Recent Developments and Future Plans
Figure 37. Steris Corporation Recent Developments and Future Plans
Figure 38. Nordion, Inc. Recent Developments and Future Plans
Figure 39. Ahlstrom Filtration LLC Recent Developments and Future Plans
Figure 40. Membrana GmbH Recent Developments and Future Plans
Figure 41. Synergy Health, Plc Recent Developments and Future Plans
Figure 42. Advanced Sterilization Products Services, Inc Recent Developments and Future Plans
Figure 43. Global Infection Control in Cancer Therapy Revenue Share by Players in 2020
Figure 44. Infection Control in Cancer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 45. Global Top 3 Players Infection Control in Cancer Therapy Revenue Market Share in 2020
Figure 46. Global Top 10 Players Infection Control in Cancer Therapy Revenue Market Share in 2020
Figure 47. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 48. Global Infection Control in Cancer Therapy Revenue Share by Type in 2020
Figure 49. Global Infection Control in Cancer Therapy Market Share Forecast by Type (2021-2026)
Figure 50. Global Infection Control in Cancer Therapy Revenue Share by Application in 2020
Figure 51. Global Infection Control in Cancer Therapy Market Share Forecast by Application (2021-2026)
Figure 52. North America Infection Control in Cancer Therapy Sales Market Share by Type (2016-2026)
Figure 53. North America Infection Control in Cancer Therapy Sales Market Share by Application (2016-2026)
Figure 54. North America Infection Control in Cancer Therapy Revenue Market Share by Country (2016-2026)
Figure 55. United States Infection Control in Cancer Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Canada Infection Control in Cancer Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Mexico Infection Control in Cancer Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Europe Infection Control in Cancer Therapy Sales Market Share by Type (2016-2026)
Figure 59. Europe Infection Control in Cancer Therapy Sales Market Share by Application (2016-2026)
Figure 60. Europe Infection Control in Cancer Therapy Revenue Market Share by Country (2016-2026)
Figure 61. Germany Infection Control in Cancer Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. France Infection Control in Cancer Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. United Kingdom Infection Control in Cancer Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Russia Infection Control in Cancer Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Italy Infection Control in Cancer Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Asia-Pacific Infection Control in Cancer Therapy Sales Market Share by Type (2016-2026)
Figure 67. Asia-Pacific Infection Control in Cancer Therapy Sales Market Share by Application (2016-2026)
Figure 68. Asia-Pacific Infection Control in Cancer Therapy Revenue Market Share by Region (2016-2026)
Figure 69. China Infection Control in Cancer Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Japan Infection Control in Cancer Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. South Korea Infection Control in Cancer Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. India Infection Control in Cancer Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Southeast Asia Infection Control in Cancer Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Australia Infection Control in Cancer Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South America Infection Control in Cancer Therapy Sales Market Share by Type (2016-2026)
Figure 76. South America Infection Control in Cancer Therapy Sales Market Share by Application (2016-2026)
Figure 77. South America Infection Control in Cancer Therapy Revenue Market Share by Country (2016-2026)
Figure 78. Brazil Infection Control in Cancer Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Argentina Infection Control in Cancer Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Middle East and Africa Infection Control in Cancer Therapy Sales Market Share by Type (2016-2026)
Figure 81. Middle East and Africa Infection Control in Cancer Therapy Sales Market Share by Application (2016-2026)
Figure 82. Middle East and Africa Infection Control in Cancer Therapy Revenue Market Share by Country (2016-2026)
Figure 83. Turkey Infection Control in Cancer Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Saudi Arabia Infection Control in Cancer Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. UAE Infection Control in Cancer Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 86. Methodology
Figure 87. Research Process and Data Source
世界の乳がん用内分泌療法薬市場 2021：企業別、地域別、種類・用途別 The Endocrine Therapy Drugs for Breast Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…- 世界のT細胞療法市場 2021：企業別、地域別、種類・用途別 The T-Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…
- 世界のMRIガイド下放射線治療システム市場 2021：企業別、地域別、種類・用途別 The MRI-guided Radiation Therapy Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 世界の放射線療法用品質保証ファントム市場 2021：企業別、地域別、種類・用途別 The Radiation Therapy Quality Assurance Phantoms market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 世界の表面放射線療法システム市場 2021：企業別、地域別、種類・用途別 The Superficial Radiation Therapy Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…